Sign in

Maria Carrillo

@mariacarrilloalz.bsky.social
275 followers 146 following 17 posts

Alzheimer's Association

PostsRepliesMedia
Maria Carrillo @mariacarrilloalz.bsky.social · 23/09/2026
Proud to share that Part the Cloud is investing nearly $7 million in 5 promising Alzheimer's therapies to help move them into clinical trials — combination strategies, a repurposed diuretic and our first AI-designed antibody therapy. Learn more: bit.ly/4ruxb02
bit.ly
Alzheimer's Association Part the Cloud Grants $7 Million to Accelerate Visionary Treatment Candidates into Clinical Trials
Funding aims to accelerate visionary Alzheimer's and dementia treatment candidates into clinical trials. To date, Part the Cloud has funded 88 trials across the globe.
011
Maria Carrillo @mariacarrilloalz.bsky.social · 24/08/2026
4 FDA-cleared blood tests for Alzheimer's diagnosis & 2 cleared within a few days of each other. It's the kind of progress we've been working toward for decades. This is the research community doing what it does best: turning ideas and discovery into real tools for real people.
000
Reposted by Maria Carrillo
Alzheimer's Association @alzassociation.bsky.social · 24/08/2026
Breaking News: Today, the U.S. Food and Drug Administration (FDA) cleared a fourth Alzheimer’s blood test for people experiencing signs or symptoms of cognitive impairment. This is the second blood-based biomarker test to be cleared in the past week. Read our statement: bit.ly/3SMm6KO.
073
Maria Carrillo @mariacarrilloalz.bsky.social · 21/08/2026
Advances like this matter for people and families seeking answers. See below for our full statement.
000
Maria Carrillo @mariacarrilloalz.bsky.social · 23/07/2026
At #AAIC26 last week, we announced PROTECT-Cog to evaluate whether combining lifestyle intervention with a metabolism-targeting drug like a GLP-1 agonist can further reduce dementia risk. That’s a $100 million commitment – in science, progress, and people.
010
Maria Carrillo @mariacarrilloalz.bsky.social · 14/07/2026
This LatAm-FINGERS news from #AAIC26 is big. Not just for science, but for the power of global scientific collaboration. www.thelancet.com/journals/lan...
thelancet.com
Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial
A culturally adapted multidomain lifestyle intervention was feasible across Latin America and resulted in greater cognitive improvements than a flexible health-advice intervention in older adults at r...
030
Maria Carrillo @mariacarrilloalz.bsky.social · 30/04/2026
This reflects an important model of innovation — finding new ways existing drugs can help people living with Alzheimer's disease — and underscores the power of science to make an impact on people and families. See below for more on this new option for managing agitation in Alzheimer’s disease.
020
Maria Carrillo @mariacarrilloalz.bsky.social · 08/01/2026
Proud to announce new Part the Cloud investments: $11 million in 11 studies developing potential new treatments for Alzheimer’s and other diseases that cause dementia. This brings our total PTC investment to $90m+. More: bit.ly/3LtnYo1
bit.ly
Alzheimer's Association Part the Cloud Grants $11 Million to Develop Innovative Treatments
Grants were awarded to 11 studies developing innovative potential new treatments for Alzheimer’s and other diseases that cause dementia.
020
Maria Carrillo @mariacarrilloalz.bsky.social · 02/10/2025
ISTAART is monitoring the potential impact of the government shutdown on researchers & the dementia care community where funds & staffing capacity are critical. Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!
001
Maria Carrillo @mariacarrilloalz.bsky.social · 19/09/2025
Proud to share the Alzheimer’s Association invested $112.2M in research activities over the last year — our largest single-year commitment. From gene therapy to #BrainHealth to risk reduction to AI, we’re funding bold boundary-pushing ideas. alz.org/research #ENDALZ
alz.org
Alzheimer's & Dementia Research | Alzheimer's Association
Alzheimer's and dementia research – find the latest update on research funding, grants, clinical trials and global research news.
042
Maria Carrillo @mariacarrilloalz.bsky.social · 29/07/2025
#AAIC2025 following USPointer recipe with a morning fun run!
050
Maria Carrillo @mariacarrilloalz.bsky.social · 29/07/2025
Today’s news from #AAIC25 marks a moment so many of us in the Alzheimer’s and dementia scientific community have long hoped for. We can now say with confidence that lifestyle interventions can protect brain health in diverse communities in the U.S.
060
Reposted by Maria Carrillo
Alzheimer's Association @alzassociation.bsky.social · 28/07/2025
📣Today is a turning point in what we know about brain health. The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S. #AAIC25 alz.org/USPOINTERresults
12313
Maria Carrillo @mariacarrilloalz.bsky.social · 18/06/2025
“This is just the beginning,” @BillGates.bsky.social wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more momentum than ever before, but now we need to go faster, earlier and bolder. That’s what @ALZAssocation’s Part the Cloud is all about.
030
Maria Carrillo @mariacarrilloalz.bsky.social · 13/06/2025
Congratulations to the recipients of the @alzassociation Part the Cloud Gene Targeting Challenge. This funding program is focused on gene editing, with the aim of developing potential therapies that change the expression of a gene at some level. bit.ly/4l8yEVx
bit.ly
Alzheimer's Association Part the Cloud Grants $5 Million to Develop Gene Targeting Treatments
Through the Alzheimer's Association, the Part the Cloud grants support development of innovative gene targeting treatments for Alzheimer's and dementia.
020
Maria Carrillo @mariacarrilloalz.bsky.social · 16/05/2025
The myths and fabrications persistently shared by the Health and Human Services Secretary aren’t just disappointing – they’re dangerous. See below for the facts and for our full statement in response to the Secretary’s comments.
11710
Reposted by Maria Carrillo
Prof Malú Gámez Tansey @malutansey.bsky.social · 14/04/2025
It was a privilege to deliver one of the keynotes at today’s #CNDSymposium Day2 @iusm-medneuro.bsky.social alongside @elizabethhead.bsky.social @mariacarrilloalz.bsky.social. Congrats to @wilcocklab.bsky.social for the amazing 2 days of science 🤓💪🏼
0234
Maria Carrillo @mariacarrilloalz.bsky.social · 25/03/2025
@alzassociation.bsky.social CEO Dr Joanne Pike and the World Dementia Council rising chair is closing a fantastic day of discussions to accelerate innovation and deliver change! #ENDALZ
030
Reposted by Maria Carrillo
Eric Siemers @esiemers.bsky.social · 22/03/2025
jamanetwork.com/journals/jam...
jamanetwork.com
The Bad Medicine of Doctored
This Viewpoint discusses a recent book that alleges scientific misconduct in Alzheimer disease (AD) research; summarizes actual progress made in the field; suggests that the book contributes to a narr...
031
Reposted by Maria Carrillo
Laura Stankeviciute, PhD @laura-sofia-s.bsky.social · 05/03/2025
📣 Join the "The Basics: Glymphatic System – A Focus on the Role of Sleep" @istaart.bsky.social webinar to learn the fundamental mechanisms of the glymphatic system and the critical role of #sleep in its function. 🧠🧼💤 📆 Register alz-org.zoom.us/webinar/regi... @claireandre.bsky.social #EndAlz
063
Maria Carrillo @mariacarrilloalz.bsky.social · 06/03/2025
Observations from today’s confirmation hearing for the director of the NIH: 1. bipartisan support for addressing dementia was on full display & 2. harmful myths about Alzheimer’s research continue to persist and that needs to stop. Our full statement: bit.ly/4bql5Nv
bit.ly
Bipartisan Support for Alzheimer’s and Dementia Research During Senate HELP Committee
Read the Alzheimer's Association statement on the Senate HELP Committee hearing for the National Institutes of Health (NIH) director nominee.
031
Maria Carrillo @mariacarrilloalz.bsky.social · 04/03/2025
So honored to be a part of this first symposium @IU @wilcocklab.bsky.social @malutansey.bsky.social to #ENDALZ
061
Reposted by Maria Carrillo
Yakeel T. Quiroz, PhD @ytquiroz.bsky.social · 12/01/2025
Join us this week in San Juan #PuertoRico for Human Amyloid Imaging Conference #HAI2025 😊 Excited to participate in a panel discussion on disparities in neuroimaging & AD research, organized by the ISTAART Neuroimaging PIA and Diversity & Disparities PIA (Prof Interest Area)🤩
media.tenor.com
Love Languages GIF
ALT: Love Languages GIF
0111
Reposted by Maria Carrillo
Melissa E. Murray @drneurochic.bsky.social · 08/01/2025
What an incredible time period to be working on updated appropriate use criteria for amyloid and tau PET! Awesome group to work with...I learned so much🧠 alz-journals.onlinelibrary.wiley.com/doi/10.1002/... @alzassociation.bsky.social @snm-mi.bsky.social
alz-journals.onlinelibrary.wiley.com
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
INTRODUCTION The Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened a multidisciplinary workgroup to update appropriate use criteria (AUC) for amyloid positro.....
2247
Reposted by Maria Carrillo
Oz Ismail @ozyismail.bsky.social · 08/01/2025
🚨 ISTAART Voices is back! 🎉 Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family. Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧
153